Home/Filings/4/0001127602-24-013656
4//SEC Filing

Himmelreich Jeffrey C 4

Accession 0001127602-24-013656

CIK 0001878313other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 5:03 PM ET

Size

5.3 KB

Accession

0001127602-24-013656

Insider Transaction Report

Form 4
Period: 2024-04-30
Himmelreich Jeffrey C
Head of Finance
Transactions
  • Award

    Stock Options

    2024-04-26+10,00010,000 total
    Exercise: $2.94Exp: 2034-04-26Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The stock options, granted on April 26, 2024 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversay of the date of the grant and the remaining options to vest ratably monthly thereafter for 36 months.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0002001189

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 5:03 PM ET
Size
5.3 KB